Mirion Technologies (MIR)

• Market cap: $3.17B
• 1 day: -2.32%
• 5 days: -3.85%
• 1 month: -11.43%
• 3 months: -21.45%
• 6 months: -6.65%
• Year to date: -20.33%
• 1 year: 21.66%
• 5 years: 35.48%
• 10 years: 35.48%
• Sector: Industrials
• Industry: Specialty Industrial Machinery

About: Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

Employees: 2,860

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

1,716% more call options, than puts

Call options by funds: $38.1M | Put options by funds: $2.1M

217% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 23

100% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 6 (+3) [Q4]

48% more capital invested

Capital invested by funds: $2.27B [Q3] → $3.36B (+$1.09B) [Q4]

45% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 56

25% more funds holding

Funds holding: 178 [Q3] → 223 (+45) [Q4]

5.51% less ownership

Funds ownership: 91.0% [Q3] → 85.49% (-5.51%) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $17 26% upside
• Avg. target: $18 34% upside
• High target: $20 48% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

B. Riley Securities Yuan Zhi 38% 1-year accuracy 3 / 8 met price target	26% upside $17	Buy Maintained	16 Apr 2025
Citigroup Andrew Kaplowitz 13% 1-year accuracy 11 / 88 met price target	26% upside $17	Buy Maintained	14 Apr 2025
Baird Robert Mason 23% 1-year accuracy 3 / 13 met price target	48% upside $20	Outperform Maintained	4 Apr 2025